Search

Your search keyword '"Matsumoto, Shingo"' showing total 766 results

Search Constraints

Start Over You searched for: Author "Matsumoto, Shingo" Remove constraint Author: "Matsumoto, Shingo" Language english Remove constraint Language: english
766 results on '"Matsumoto, Shingo"'

Search Results

9. Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop: Results from LC-SCRUM-Asia

11. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

12. Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma

22. Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia study

26. Glasgow prognostic score can be a prognostic indicator after percutaneous coronary intervention: a two-center study in Japan

27. The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinoma

31. Phosphorus Dynamics in Japanese Blueberry Field: Long-Term Accumulation and Fractionation across Soil Types and Depths.

32. Beta‐blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.

33. The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

34. Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC

35. A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer

36. Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors

41. Suitability of frozen cell pellets from cytology specimens for the Amoy 9‐in‐1 assay in patients with non‐small cell lung cancer.

42. Identification of Genomic Predictors of Muscle Fiber Size.

43. Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF.

45. Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations

49. A Minimum Of 100 Tumor Cells in a Single Biopsy Sample Is Required to Assess Programmed Cell Death Ligand 1 Expression in Predicting Patient Response to Nivolumab Treatment in Nonsquamous Non–Small Cell Lung Carcinoma

Catalog

Books, media, physical & digital resources